Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aldolase plays essential catalytic roles in glycolysis and gluconeogenesis. However,
aldolase
is a highly abundant protein that is remarkably promiscuous in its interactions with other cellular proteins. In particular,
aldolase
binds to highly acidic amino acid sequences, including the C terminus of the Wiskott-Aldrich syndrome protein, an actin nucleation-promoting factor. Here we report the crystal structure of tetrameric rabbit muscle
aldolase
in complex with a C-terminal peptide of Wiskott-Aldrich syndrome protein. Aldolase recognizes a short, four-residue DEWD motif (residues 498-501), which adopts a loose hairpin turn that folds around the central aromatic residue, enabling its tryptophan side chain to fit into a hydrophobic pocket in the active site of
aldolase
. The flanking acidic residues in this binding motif provide further interactions with conserved
aldolase
active site residues Arg-42 and Arg-303, aligning their side chains and forming the sides of the hydrophobic pocket. The binding of Wiskott-Aldrich syndrome protein to
aldolase
precludes intramolecular interactions of its C terminus with its active site and is competitive with substrate as well as with binding by actin and
cortactin
. Finally, based on this structure, a novel naphthol phosphate-based inhibitor of
aldolase
was identified, and its structure in complex with
aldolase
demonstrated mimicry of the Wiskott-Aldrich syndrome protein-
aldolase
interaction. The data support a model whereby
aldolase
exists in distinct forms that regulate glycolysis or actin dynamics.
...
PMID:A hydrophobic pocket in the active site of glycolytic aldolase mediates interactions with Wiskott-Aldrich syndrome protein. 1732 59